(PharmaNewsWire.Com, December 22, 2017 ) According to the report Middle East and Africa Anti-venom Market, published by Market Data Forecast, the market is projected to reach USD 124.2 million by 2021, at a CAGR of 6.67% from 2016 to 2021. To overcome poisonous effects after venomous bites the manufacturers developed number of Anti-venom products including vaccines and hyperimmune sera.
Anti-venom is manufactured from the venom of animals like snakes, spiders, scorpions and various other poisonous animals. Venomous bites often lead to adverse symptoms like excessive secretion of saliva, muscle weakness, breathing issues and may be fatal sometimes. The specific Anti-venom needed depends on the species involved. It is given by injection.
Anti-venom Market: Drivers & Restraints The growth of the market is driven by the factors like increasing reports of snake bites cases compared to developed regions, development of effective anti-venom products against more number of snake species and increasing focus of manufacturers on anti-venom products in this region. However, limited availability of the products, high cost, increasing regulations and requirement of training for medical staff are the factors confining the growth of market.
Anti-venom Market: Overview Snakebite is a recognized medical emergency in developing countries where majority of people are people living in rural communities, with children and agricultural workers most at risk. The declining anti-venom availability and rising mortality due to snake bites in the developing countries is pushing the demand for anti-venoms.
Anti-venom Market: Region-wise Outlook Geographically this market is analysed under various regions namely Middle East and Africa. UAE is the leading market in this region.
Key Questions Answered What is the current and future Anti-venom Market outlook in Middle East and Africa? What trends are affecting the market? What is the competitive landscape and market share of major players in the Anti-venom Market space in Middle East and Africa? What are the key, high growth markets that Anti-venom Market manufacturers should expand into? Which market segments are growing the fastest? What are the unmet needs with the Anti-venom currently on the market? How will emerging technologies fulfil these unmet needs? What is end-user perception and market outlook of Anti-venom? What are the challenges and barriers that have hindered widespread adoption of Anti-venom?
Anti-venom Market: Key Players Some of the major companies dominating the market, by their products include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).
Reasons to buy Anti-venom Market Report: Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
